A recent Phase 3 clinical trial demonstrated that a steroid-free topical foam, roflumilast (Zoryve), significantly improved the signs and symptoms of psoriasis on both the scalp and body. The foam ...

Psoriasis is one of the most common chronic inflammatory skin diseases, affecting about 250,000 people in Austria. While previous treatment approaches have mainly focused on inhibiting ...

For people with moderate to severe psoriasis, highly targeted antibody-based treatments introduced in the past 10–15 years have been life changing. Inflamed skin covering swathes of the body often ...

While each product featured is independently selected by our editors, we may include paid promotion. If you buy something through our links, we may earn commission. Read more about our Product Review ...

Sept. 19, 2025 -- Psoriasis is more than skin deep -- it’s a chronic inflammatory condition that raises the risk of serious health issues like depression, heart disease, and substance use. An emerging ...

GLP-1 agonists appeared to have a bigger impact on the physical and mental health of patients with psoriasis compared with other patients, a large retrospective cohort study showed. Reductions in ...

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for 'leaky gut', according to new research. These changes in the gut ...

SAN DIEGO — While psoriasis is linked to higher rates of dementia, a new study suggested that older patients with psoriasis on systemic treatments may have a much lower risk than those not treated ...